Zhonghua Wang - Concepedia

Author

Zhonghua Wang

Fudan University Shanghai Cancer Center ORCID

Also Known As

Wang Zhong-hua, Wang, Zhonghua, Yanxiang Li, Z. Wang, Z., Wang, Zhong-Hua Wang, Zhong-hua Wang, Zhonghua Wang, zhonghua wang

107

Publications

Citations

H-Index

Concepts

All Affiliations

Fudan University Shanghai Cancer Center Shanghai Medical College of Fudan University Harbin Medical University Jiangsu Hengrui Medicine (China)Third Affiliated Hospital of Harbin Medical University

About

Zhonghua Wang is an author at Fudan University Shanghai Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	346
2	Engineering	1	1	11
3	Health Sciences	1	1	24
4	Public Health	1	1	39
5	Biochemistry	1	1	16

Zhonghua Wang

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer Xichun Hu, Jian Zhang, Binghe Xu, International Journal of Cancer	2014	267
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer Xichun Hu, Jun Cao, Wenwei Hu, BMC Cancer	2014	233
Adipocytokines and Lipid Levels in Ames Dwarf and Calorie-Restricted Mice Zhonghua Wang, Khalid Al-Regaiey, Michał M. Masternak, The Journals of Gerontology Series A	2006	99
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial Song‐Yang Wu, Ying Xu, Li Chen, Molecular Cancer	2022	90
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu, Clinical Cancer Research	2022	89
In situ metabolomics in nephrotoxicity of aristolochic acids based on air flow-assisted desorption electrospray ionization mass spectrometry imaging Zhonghua Wang, Bingshu He, Yaqi Liu, Acta Pharmaceutica Sinica B	2019	85
Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L Rujiao Liu, Jun Cao, Xiang Gao, Tumor Biology Breast OncologyMedicineCancer ManagementHigh LevelPathology	2016	75
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer Biyun Wang, Tao Sun, Yannan Zhao, Nature Communications	2022	70
A randomized phase II study of aromatase inhibitors plus metformin in pre-treated postmenopausal patients with hormone receptor positive metastatic breast cancer Yannan Zhao, Chengcheng Gong, Zhonghua Wang, Oncotarget	2017	63
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trial Yin Liu, Xiu-Zhi Zhu, Yi Xiao, Cell Research	2023	63

Page 1